| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Shrikrishan Jindal Appointed as Managing Director since October 2011 | Managing Director | 01-Oct-2011 | Current |
Aashna Ajay Jindal Appointed as Whole-time director since October 2017 | Whole-time director | 24-Oct-2017 | Current |
Ishaan Jindal Appointed as Whole-time director since July 2019 | Whole-time director | 08-Jul-2019 | Current |
Krishnabai Shrikrishan Jindal Appointed as Whole-time director since March 2015 | Whole-time director | 23-Mar-2015 | Current |
Mamta Ajay Jindal Appointed as Whole-time director since March 2015 | Whole-time director | 23-Mar-2015 | Current |
Shrikrishan Parameshwaridas Jindal Appointed as Whole-time director since October 2011 | Whole-time director | 01-Oct-2011 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Jindal Drugs Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Jindal Drugs Private Limited's leadership journey.
Loading...
Contact Details
- Address 12A, Bakhtawar, 12Th Floor, 229 Nariman Point,, Mumbai Maharashtra, 400021, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 400021
- Country India
- Website jindaldrugs.com
- Social Media
Frequently Asked Questions
You can contact Jindal Drugs Private Limited through their registered address at 12A, Bakhtawar, 12Th Floor, 229 Nariman Point,, Mumbai Maharashtra, 400021, India, or via their website at jindaldrugs.com. Social media links are also provided where applicable.
The current directors of Jindal Drugs Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- MAMTA AJAY JINDAL
- ISHAAN JINDAL
- AJAY SHRIKRISHAN JINDAL
- SHRIKRISHAN PARAMESHWARIDAS JINDAL
- KRISHNABAI SHRIKRISHAN JINDAL
- AASHNA AJAY JINDAL
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.